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Abstract
Background: Tobacco and cannabis use are strongly interrelated, but current national and international cessation
programs typically focus on one substance, and address the other substance either only marginally or not at all.
This study aimed to identify the demand for, and describe the development and content of, the first integrative
group cessation program for co-smokers of cigarettes and cannabis.
Methods: First, a preliminary study using expert interviews, user focus groups with (ex-)smokers, and an online
survey was conducted to investigate the demand for, and potential content of, an integrative smoking cessation
program (ISCP) for tobacco and cannabis co-smokers. This study revealed that both experts and co-smokers
considered an ISCP to be useful but expected only modest levels of readiness for participation.
Based on the findings of the preliminary study, an interdisciplinary expert team developed a course concept and a
recruitment strategy. The developed group cessation program is based on current treatment techniques (such as
motivational interviewing, cognitive behavioural therapy, and self-control training) and structured into six course
sessions.
The program was evaluated regarding its acceptability among participants and course instructors.
Results: Both the participants and course instructors evaluated the course positively. Participants and instructors
especially appreciated the group discussions and the modules that were aimed at developing personal strategies
that could be applied during simultaneous cessation of tobacco and cannabis, such as dealing with craving,
withdrawal, and high-risk situations.
Conclusions: There is a clear demand for a double cessation program for co-users of cigarettes and cannabis, and
the first group cessation program tailored for these users has been developed and evaluated for acceptability. In
the near future, the feasibility of the program will be evaluated.
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Background
Tobacco and cannabis are interrelated in a unique, multi-
dimensional manner, with some connecting mechanisms
that are distinct from the co-use of drugs in general [1].
Two of them are the shared route of administration (i.e.,
both substances are smoked) and co-administration
(“mulling”, i.e., adding tobacco to cannabis joints, or
blunts, i.e., rolling cannabis in cigar paper). Mulling is the
most common way of using cannabis in Europe [2]. Epi-
demiological data show that tobacco smoking is more
prevalent among those who consume cannabis compared
to the total population. In a study in the United States,
74% of the marijuana users smoked cigarettes compared
to 29% of the nonusers [3]. On the other hand, cannabis
use is more common among tobacco smokers than among
tobacco abstainers. In the National Survey on Drug Use
and Health (NSDUH) in the United States, the 30 days
prevalence of cannabis use was 36% among tobacco
smokers compared to 11% among non-smokers [4]. In a
general population survey on tobacco use in Switzerland,
cannabis use during the 12 months before the survey was
reported by 28% of the adolescents who smoked tobacco
daily compared to 9% and 2% of the adolescents who were
ex- and never-smokers, respectively [5].
Investigations examining the initiation of use, the tran-
sition to regular use, and the cessation of tobacco and
cannabis use exemplify this interrelation. Tobacco use
can act as a gateway to cannabis use [6], but the reverse,
i.e., cannabis use acting as a gateway to tobacco use, has
also been observed [7,8]. Additionally, the probability of
a transition from occasional to regular tobacco smoking
and nicotine dependence is higher in smokers who also
use cannabis [7,9]. Similarly, (adolescent) cannabis users
who also smoke tobacco seem to be at higher risk for
regular cannabis use and cannabis dependence in young
adulthood compared with cannabis-only users [10].
Regarding the cessation of tobacco use, longitudinal ob-
servational studies have demonstrated that tobacco
smokers who also consumed cannabis made fewer at-
tempts to quit using tobacco [11] and were less likely to
successfully quit using tobacco compared with tobacco-
only smokers [12]. Furthermore, cessation programs that
exclusively address tobacco consumption appear to be less
effective for individuals who also consume cannabis
[13,14]. A balancing effect is one problem that co-smokers
may be confronted with when wanting to stop using only
one of the substances. It has been shown that the cessation
of one substance often co-occurs with an increased use of
the other substance [15-17]. These findings highlight the
importance of accounting for concurrent tobacco and can-
nabis use when planning and evaluating interventions.
Despite this evidence, current cessation programs typ-
ically focus on one substance while only addressing the
other substance either marginally or not at all. To our
knowledge, no integrative smoking cessation program
(ISCP) targeting co-smokers of cigarettes and cannabis
in a group setting has been designed.
However, results of concurrent treatments of tobacco
and alcohol dependence [18,19] and tobacco and illicit
substance use (e.g., opiates; [20]) have been published.
Additionally, some brief interventions targeting multiple
substance use have shown promising results [21-23].
These findings demonstrate that it is feasible to combine a
tobacco cessation intervention with an intervention that
targets a second substance. Compared with single inter-
ventions, double interventions do not necessarily over-
strain participants and reduce abstinence rates; instead,
they generate putatively better outcomes with regard to
one or both targeted behaviours [24,25].
The separate treatment histories surrounding tobacco
and cannabis may be explained by the different legal sta-
tuses of the two substances that are often the subject of
political discourse and election campaigns. In Switzerland
for example, tobacco is categorised as a licit substance,
while cannabis is an illicit drug. The divisions of the Swiss
government that deal with these substances are both or-
ganisationally and financially separated from each other
and, currently, so is the funding for prevention programs
and research projects. Another explanation for the lack of
combined treatment for tobacco and cannabis use may be
the historical development of treatment and prevention
systems in many industrialised countries. Treatment of
cannabis dependence and co-occurring mental health
problems is provided by the psychiatric systems of many
countries. In contrast, tobacco cessation is possible with-
out the involvement of psychiatrists and is part of the
more general public health systems [24,25] that typically
involve general health supply services. In Switzerland,
health insurance coverage differs between the substances;
while cannabis treatment in psychiatric services is covered
by basic health insurance, smokers themselves are re-
quired to pay for nicotine replacement therapy and
courses for tobacco cessation.
In recent reviews, researchers have stressed the need to
develop and evaluate combined interventions for tobacco
and cannabis users [1,26,27]. Agrawal and colleagues
found evidence that dual abstinence may predict better
cessation outcomes and therefore suggested developing
out-patient treatment models [1].
The aim of the current study was to develop an ISCP.
This process was accomplished in three steps, which will
be explicated in this report. First, a preliminary study
clarified whether there was a demand for an ISCP. Second,
after having identified the demand, explicit information
regarding co-smokers’ attitudes towards tobacco and can-
nabis and the association between both substances was
collected for use when developing an ISCP. Moreover, co-
smokers’ relevant experiences regarding quitting one or
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both substances simultaneously were collected. Third,
based on the information gained during the second step,
an ISCP was developed tailored to co-smokers of ciga-
rettes and cannabis. This program incorporates the
established therapeutic principles and strategies of former
tobacco and cannabis cessation programs and takes into
account reasonable concepts and ideas from the ongoing
discussion about the mechanisms underlying the co-use
of tobacco and cannabis and potential dependency
problems.
Methods
Preliminary study and demand analysis
The perception of and the need for an ISCP were explored
with semi-structured qualitative interviews with addiction
experts, qualitative age-specific user focus groups, and a
quantitative online survey designed for current and former
co-smokers. Qualitative data were analysed according to
the coding procedures of Grounded Theory [28]. Quantita-
tive data were examined with descriptive statistics and lo-
gistic regression analyses, which were conducted to
identify predictors of readiness to simultaneously quit ciga-
rettes and cannabis. First, bivariate logistic regression ana-
lyses were used to identify potential predictors. These
predictors were then entered into one model. Next, non-
significant variables (p ≥ .05) were removed successively
from the multivariate model. The resulting model was veri-
fied by separately adding the excluded variables to the
model to account for suppressor effects. Only significant
predictors (p < .05) were retained in the final model. In
these analyses, only the respondents currently smoking cig-
arettes and using cannabis were included. All quantitative
analyses were conducted using PASW Statistics Version 18
and 20 (SPSS Inc., Chicago, IL, USA).
Expert interviews
Twelve addiction experts participated in the semi-structured
interviews about the relationship between tobacco and can-
nabis use and the demand for and possible design of an
ISCP. These addiction experts worked in research or were
practicing psychotherapy, medicine, prevention, or epidemi-
ology. The majority were known local experts in tobacco
and/or cannabis use. The experts were reimbursed with 180
Swiss Francs (corresponding to about 167 US dollars in Feb-
ruary 2010 when the interviews were conducted). Most of
the experts emphasised a substantial relationship between
tobacco and cannabis use that can cause problems, espe-
cially in the context of cessation attempts. For example,
some experts observed that individuals who consumed both
tobacco and cannabis increased their use of one substance
when attempting to quit the other, which could lead to ele-
vated risk of relapse. Quitting both substances simultan-
eously might prevent this balancing effect. Thus, the experts
perceived a clear demand for an ISCP. Despite this demand,
the experts assumed that few co-smokers would be ready to
stop their tobacco and cannabis use simultaneously because
smokers often perceived quitting tobacco use as a “loss” and
probably would not be ready to additionally “give up” canna-
bis use.
Regarding the design of an ISCP, the experts favoured
a group setting and suggested incorporating methods
from cannabis treatment manuals into an established to-
bacco cessation program. The experts believed that inte-
grating an additional substance into a tobacco cessation
program would enhance its complexity (e.g., they
expected a relatively high rate of participants with psy-
chiatric comorbidities such as depression). Thus, an
ISCP should offer comprehensive medical, psychiatric,
and psychotherapeutic support for participants, on-
demand additional single treatment sessions, and spe-
cific training for the course instructors that would aid in
addressing the complexities and potential problems of
double cessation.
The experts differed in their opinions about the appro-
priate age range of the participants. However, some ex-
perts suggested that co-smokers aged 25 years and
above should be targeted because the experts expected a
higher level of readiness to participate in an ISCP among
this age group compared with younger co-smokers. This
reasoning was based on the common assumption that
cannabis use during adolescence is transient and thus
less problematic and on the fact that family planning
usually becomes more relevant at the age of 25 years.
Two experts suggested separating groups by gender.
Focus groups with former and current co-smokers
The focus group discussions were conducted to gain in-
depth information concerning users’ problems, experi-
ences, and methods of coping with the issues that oc-
curred during cessation attempts. Recruitment was
organised via counselling facilities, and participants re-
ceived financial reimbursement for participation. To be
included in the focus group discussions, candidate par-
ticipants had to self-report 1) past or current tobacco
dependence, 2) past or current use of cannabis at least
several times per week, and 3) at least one attempt to
quit cigarette smoking, cannabis use, or both with for-
mal treatment. As an incentive, focus group participants
received 100 Swiss Francs in cash (corresponding to
about 95 US dollars in April 2010 when the focus groups
were conducted).
Similar to the experts, the 14 participants of the focus
group discussions (10 adolescents aged 16 to 22 years
and four adults aged 27 to 39 years) perceived a strong
relationship between tobacco and cannabis use. Many of
the participants reported experiences with the aforemen-
tioned balancing effect. However, the adolescents in par-
ticular demonstrated low willingness to quit cannabis
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and discussed their negative outcome expectancies
concerning tobacco and cannabis cessation attempts (e.g.,
weight gain, sleeplessness, and increased alcohol consump-
tion). The participants assumed that the general willing-
ness of co-smokers to quit both substances would be low.
However, due to the relationship between tobacco and can-
nabis use, they considered an ISCP to be useful.
Regarding the ISCP design, participants emphasised the
importance of appropriate knowledge transfer concerning
the interrelationship of the substances. The participants
deemed the differences between potential participants with
regard to their motivations to quit, aims, consumption pat-
terns, and life situations to be relevant. Therefore, they
suggested that all course participants should form a com-
mon goal. Furthermore, focus group participants indicated
that there was a strong need for the development of appro-
priate relaxation and stress reduction methods.
Online survey with former and current co-smokers
Taking into account the information provided by the ex-
pert interviews and user focus groups, the online survey
included questions concerning smoking behaviour, quit-
ting experiences, and attitudes towards tobacco, cannabis,
and an ISCP. Moreover, the online survey investigated the
demand for an ISCP, co-smokers’ willingness to participate
in such a program, and their readiness to quit both
substances simultaneously. Former co-smokers were
asked to indicate whether they would have been willing
to participate in an ISCP and whether they would have
been ready to quit tobacco and cannabis simultaneously.
Recruitment was achieved through advertisements in
internet forums on smoking, cannabis use, and health
and via two social media platforms. Lotteries for a city
trip, a tablet computer, and book vouchers were used to
encourage participation.
The online survey began with 247 respondents who met
the inclusion criteria of smoking both tobacco and cannabis
either regularly at the time of the survey (current co-users,
n = 109) or in the past (n = 138). Current co-use was defined
as daily tobacco use and the use of cannabis during the past
seven days before the survey. The survey was completed by
79.4% (196/247). Data from drop-outs were excluded in an
item-wise manner. There were no significant differences be-
tween the drop-outs and the completers regarding age (U=
4908.50, p= .844), sex (χ2(1) = 0.368, p= .636), educational
level (U = 4751.5, p= .581), or smoking frequency (tobacco:
U = 4560.0, p= .289; cannabis: U = 4616.5, p= .397).
The respondents were between the ages of 14 and
88 years (M = 28.71, SD = 8.46), and 44.9% (111/247)
were female. More than half of the respondents had pre-
viously attempted to stop smoking tobacco (74.7%, 183/
245) and/or cannabis (51.2%, 124/242) at least once. Of
those who had attempted to quit tobacco, 19 respon-
dents (33.3%) increased their cannabis use after their
tobacco cessation. More than half (51.6%) of those who
had attempted to quit cannabis reported an increase in
tobacco use.
As shown in Table 1, smokers’ potential and ex-
smokers’ actual reasons for quitting differed significantly
according to the substance (tobacco or cannabis). Rea-
sons for quitting tobacco use were related to physical
health aspects, whereas the most common reasons for
cannabis cessation were problems with memory, concen-
tration, motivation, and achievement. Respondents could
also specify further reasons, which were not included in
the list. The listed reasons were quite heterogeneous.
However, several respondents mentioned the lack of de-
sire to smoke tobacco and/or cannabis as a potential or
actual reason to quit. For tobacco use, several respon-
dents listed olfactory or gustatory reasons for quitting,
and for cannabis use, some respondents mentioned that
they experienced no effects or negative effects after the
use of the substance as a reason for quitting.
Table 2 shows attitudes towards the potential negative
effects of tobacco and cannabis smoking. Compared to
the analogous statements for cannabis smoking, a sig-
nificantly higher proportion of respondents confirmed
the statements concerning the negative effects of to-
bacco smoking.
Half of the respondents (124/247) thought that smok-
ing tobacco and cannabis were interrelated (33.6%
responded “yes probably”, and 16.6% responded “yes”).
Furthermore, 67.6% (140/207) of the respondents af-
firmed the need for an ISCP (22.2% responded “yes”, and
45.5% responded “yes probably”).
However, of those who were currently smoking to-
bacco and using cannabis only 27.6% (29/105, 95% confi-
dence interval [CI] = 0.20–0.37) stated that they felt
ready to quit both substances simultaneously (15.6%
responded “yes”, and 11.0% responded “yes probably”),
and 41.4% (36/87, 95% CI = .31–.52) felt ready to partici-
pate in an ISCP (10.1% responded “yes”, and 22.9%
responded “yes probably”).
Three predictors significantly predicted readiness to
quit tobacco and cannabis simultaneously in a logistic
regression analysis. Age was positively associated with
readiness for simultaneous cessation (odds ratio [OR] =
1.11, 95% CI = 1.03–1.19, p = .005). Furthermore, using
cannabis at least once a week predicted a lower likeli-
hood of feeling ready to quit compared with using can-
nabis less frequently (OR = 0.12, 95% CI = 0.04–0.40,
p = .001). Finally, partial or full agreement with the state-
ment “Cannabis is harmful to my health” increased the
likelihood of readiness to quit the substances simultan-
eously (OR = 4.13, 95% CI = 1.43–11.94, p = .009).
With regard to the program design, more than 70%
(127/179) of the respondents considered an ISCP useful
for individuals between 20 and 25 years and more than
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half of the respondents found it useful for those between
15 and 20 years (101/179) and for those between 25 and
30 years (98/179; multiple answers possible). In general,
69.9% (137/196) of the respondents preferred age-
separated but only 14.3% (28/196) preferred sex-
separated groups. The majority of the respondents
(66.9%, 131/196) also suggested making the groups ac-
cessible only to smokers of both substances.
Conceptualisation of the intervention
Given that both experts and co-smokers considered a
therapeutic program for co-smokers as important and
sensible, the development process was continued.
The intervention development proceeded as follows:
first, literature was reviewed concerning effective inter-
ventions for tobacco and those for cannabis. Based on
these findings and the results of the preliminary study,
an interdisciplinary expert team composed of three psy-
chologists, one social education worker, and three psy-
chiatrists developed the group intervention. The team
members had experience (and expertise) in research,
therapeutic practice (single and group interventions for
tobacco, alcohol, and illegal drugs), and/or the develop-
ment of intervention programs for the treatment of sub-
stance abuse. The program development was an
incremental and iterative process that provided the team
members with multiple opportunities for feedback. The
experts met eight times during the seven months before
the beginning of the course. During and after the first
implementation phase, the experts held two further
meetings to adapt the manual for the second implemen-
tation phase.
Additionally, a thorough recruitment strategy was
designed to reach as many co-smokers as possible and
motivate them to participate in the ISCP. The recruit-
ment process was conceptualised as an integral part of
the ISCP and acted as an intervention in and of itself.
Therefore, this recruitment strategy will be described in
detail in the following chapter about the ISCP.
After the first implementation phase, the intervention
was slightly refined based on the feedback of the course
facilitators, some of whom were also part of the expert
team. Given that there were only minor changes (i.e., the
addition of a sixth course session that did not add con-
tent, as it only redistributed the course contents over six
instead of five sessions), in the following chapter not
both versions are described but only the adapted, second
version.
Description of the integrative cessation program for co-
smokers of cigarettes and cannabis
Recruitment strategy
The recruitment strategy was planned extensively given
that both the experts and focus group participants
Table 1 Reasons for quitting tobacco and cannabis use among online survey respondents (n = 219)
Which have been or could be reasons
for you to quit tobacco/cannabis?
Multiple answers possible.
n (%) of respondents who checked each reason for quitting tobacco/cannabis McNemar test
Tobacco Cannabis χ2 p
Problems with health 145 (66.2) 102 (46.6) 22.33 < 0.001
Decreasing physical fitness 134 (61.2) 77 (35.2) 40.73 < 0.001
Pregnancy/starting a family 87 (39.7) 73 (33.3) 4.97 0.026
Financial reasons 70 (32.0) 57 (26.0) 2.82 0.093
Non-smoking partner 69 (31.5) 43 (19.6) 14.20 < 0.001
Feeling of being dependent/not free 113 (51.6) 79 (36.1) 13.28 < 0.001
Problems with memory or concentration 37 (16.9) 112 (51.1) 62.94 < 0.001
Problems with motivation or achievement 47 (21.5) 113 (51.6) 52.81 < 0.001
Mental health problems 39 (17.8) 100 (45.7) 53.73 < 0.001
Other 21 (9.6) 32 (14.6) 3.45 0.063
McNemar’s χ2 with continuity correction.
Table 2 Attitudes towards tobacco and cannabis use among online survey respondents of the preliminary study (n = 216)
Smoking tobacco/cannabis… Tobacco Cannabis Wilcoxon signed-rank test
n (%) n (%) z p
…is harmful to my health 197 (91.2) 114 (52.8) −8.38 < 0.001
…can cause lung cancer, heart diseases and other serious diseases 190 (88.0) 122 (56.5) −7.52 < 0.001
…is addictive 185 (85.6) 81 (37.5) −9.13 < 0.001
…promotes premature skin aging and harms one’s appearance 147 (68.1) 75 (34.7) −8.43 < 0.001
Items could be answered with “I fully agree”, “I somewhat agree”, “I somewhat disagree”, or “I fully disagree”, n (%) for “I fully agree” responses are displayed.
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anticipated in the preliminary study that co-smokers
would only show modest willingness to quit their to-
bacco and cannabis use simultaneously and to partici-
pate in an ICSP. To reach as many co-smokers as
possible, information about the new course was spread
via different channels.
First, a website (www.i-cut.ch) consisting of two parts
was designed. The first part provided information about
the course (i.e., content, structure, and dates) and the
possibility to register for an information evening. The
second part aimed to enhance co-smokers’ motivation to
quit simultaneously and participate in the ISCP, primar-
ily by providing information, offering a self-assessment
with normative feedback, and using techniques adapted
from motivational interviewing [29].
During the next step, a press release was issued. This
step occurred only once at the beginning of the study and
attracted a great deal of interest, which resulted in several
reports in local newspapers and on radio and TV stations.
Counselling centres for addiction prevention and treat-
ment, psychiatrists, and health (care) centres in the canton
of Zurich and bordering cantons helped spread flyers and
leaflets that referred to the website for more information.
Additionally, two social media platforms and an advertise-
ment in the online edition of a popular free newspaper
were used for online recruitment, also referring to the
program website for more information.
The final step involved planning an information even-
ing. Interested co-smokers could attend it without any
obligation to participate in the course. The information
evening provided the opportunity to ask questions that
were answered by the course instructors, who intro-
duced themselves and the course program and presented
some background information. As central issues, they
emphasised the association between tobacco and canna-
bis use and the potential physical harm of cannabis use,
which was underestimated by co-smokers in the prelim-
inary study. Additionally, instructors mentioned that co-
smokers could participate together with co-smoking
friends and partners to start the behavioural change to-
gether and support one another.
Course setting
Consistent with the findings from the preliminary study,
the expert team considered an outpatient group-setting
with 8 to 12 co-users of tobacco (who smoked at least
one cigarette per day) and cannabis (who smoked at
least once a week) per group as appropriate. The group-
setting was preferred due to several general advantages
of group therapy, such as cost-effectiveness (fewer treat-
ment personnel are needed) and interpersonal processes
(e.g., peer support and peer pressure) [30]. Additionally,
in this new field of dual cessation of tobacco and canna-
bis use, the opportunity of group participants to share
cessation experiences and strategies was considered es-
pecially important. Given that the co-smokers in the
preliminary study preferred age-specific groups, we set
the minimum age for participation in the ISCP at
20 years. Adolescents were excluded from this first version
of the intervention for two reasons. First, being younger
was associated with a decreased readiness to quit tobacco
and cannabis simultaneously among the online survey re-
spondents of the preliminary study. This finding is in line
with the assumption of some of the interviewed experts in
the preliminary study who expected greater readiness to
participate among co-smokers aged 25 years and above.
Second, an effective ISCP for adolescents should presum-
ably differ from an ISCP designed for adults; for example,
an ISCP for adolescents should account for school and
family problems. Thus, the expert team decided to develop
a basic program version for adults that could be adapted
for adolescents if the basic version proved to be feasible.
Separating groups by gender was considered but deemed
to be unfeasible due to the expected low number of co-
smokers who were ready for participation. Furthermore,
the online survey respondents in the preliminary study
clearly preferred age-specificity to gender-specificity.
Two local addiction treatment centres in the Swiss cities
of Zurich and Winterthur offered the courses. Each course
was guided by two course instructors, at least one of
whom had to be a psychiatrist to guarantee the offer of
prescription pharmacotherapy to reduce acute withdrawal
symptoms or eventual exacerbations of severe psychiatric
symptoms. The second instructor had to have experience
in treating tobacco or cannabis smokers and could be
from a different profession. The members of the expert
team either guided the course sessions themselves or
trained additional instructors to do so. All instructors re-
ceived a therapist manual containing instructions for guid-
ing the sessions and the information that was provided to
the participants in their workbook (see below).
Course structure, content, and goals
The experts interviewed during the preliminary study
recommended using an established tobacco cessation
program as the basis for the ISCP and combining it with
cannabis-specific elements. We therefore utilised parts
of the group tobacco cessation course used by the UK’s
leading charity for gay men’s health (GMFA), which was
evaluated by Harding and colleagues [31] and with
which we were familiar, given that we culturally adapted
and scientifically evaluated this program for Switzerland.
We integrated elements from cannabis interventions
that were ongoing under the supervision of members of
the expert team. The resulting course was structured
into six weekly sessions and one revival meeting that oc-
curred approximately six weeks after the last session
(Figure 1). Given anticipated recruitment problems, the
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expert team chose a small number of sessions to gener-
ate a low-threshold intervention. Each of the sessions
lasted between 90 and 120 minutes. Additionally, course
instructors offered each participant one individual coun-
selling session on request.
Subsidiary elements of the course sessions were a
smoking diary and workbook which were introduced
and distributed to the participants during the first ses-
sion. The workbook contained background information,
an overview of the course structure and content, and
work sheets to reflect on personal reasons for cessation
and develop and write down personal strategies. The
smoking diary was a small notebook that could easily be
carried to constantly monitor consumption and thoughts,
feelings, and actions associated with the use of one or
both of the substances. The notebook should promote
vigilance and self-examination. Furthermore, partici-
pants measured their expired carbon monoxide at
every session to receive an immediate objective feed-
back on their therapy progress and for later program
evaluation. They could enter their individual values in
their notebooks and thereby monitor the changes in
the values.
The main goal of the intervention was dual abstinence
of tobacco and cannabis. The instructors promoted mod-
eration of tobacco and/or cannabis use, for example, redu-
cing smoking frequency or changing to a less harmful
method of administration (e.g., consuming cannabis orally
based on medical cannabis use recommendations for se-
vere treatment resistant diseases) only when participants
failed to quit several times during the course. This was
done to avoid course dropout. Regarding the cessation se-
quence of tobacco and cannabis, the expert team sup-
ported a simultaneous cessation with one fixed quit date
(Quit Day), when the participants were required to stop
their tobacco and cannabis use, which is in line with
Agrawal’s suggestions [1]. Before that date, participants
could either maintain their normal use of tobacco and
cannabis or start to reduce or stop one or both substances.
Apart from the importance of having a common goal, i.e.,
stopping the use of both substances on a fixed quit date
(at the latest) to foster group dynamics, this procedure
1-2 weeks 
4-6 weeks 
MODULE CONTENTS TECHNIQUES 
Background information 
Information about course structure 
Decision for or against 
participation and registration  
Presentation of course 
Psycho-educative knowledge 
transfer  
Introduction of information 
material to take home 
Question and answer session  
Getting to know each other 
Distribution and introduction of 
course material: workbook and 
consumption diary 
Pro & Con 
Quiz (optional) 
Providing basic information 
Group discussions 
Worksheet  
CO measurement  
Account of (previous) smoking 
behaviour with diary 
Finding alternative rituals 
Dealing with withdrawal symptoms 
Goal setting  
Analysis of consumption diary 
Providing basic information 
Group discussions 
Worksheets 
CO measurement  
QUIT DAY  
Account of (previous) smoking 
behaviour with diary 
Formation of quit teams  
Dealing with craving  
Dealing with lapses  
Quit Day beneficial cessation 
ritual (optional) 
Analysis of consumption diary 
Providing basic information 
Group discussions 
Worksheets 
CO measurement  
Account of first (smokeless) week 
after Quit Day 
Adaptation of personal strategies  
Handling of high-risk situations 
Group discussions 
Providing basic information 
Worksheets 
CO measurement  
Account of second (smokeless) 
week after Quit Day 
Adaptation of strategies  
Handling of social risk situations 
Group discussions 
Providing basic information 
Worksheets  
Role play (optional) 
CO measurement  
Preserving achievements  
Outlook  
Group discussions 
CO measurement  
w
e
e
kl
y 
Information  
evening 
Session 2 
Session 3 
Session 4 
Session 5 
Session 6 
Informal exchange of experiences  Group discussions Revival  
meeting 
Session 1 
Figure 1 Course structure, content, and techniques of the integrative cessation program for tobacco and cannabis co-smokers. Legend:
CO = carbon monoxide.
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was chosen for several reasons. First, the strong associ-
ation between tobacco and cannabis use, in that each sub-
stance may act as a behavioural cue for the other [32],
suggests that using neither substance is likely the easiest
manner of quitting. In addition, this strategy has the ad-
vantage of experiencing only one withdrawal phase. With-
drawal symptoms may be stronger for the cessation of
both substances compared with the symptoms for each
substance alone, yet evidence suggests that this difference
occurs for only a short duration and varies substantially
between individuals [33]. For some quitters, withdrawal
during dual abstinence may even be less severe than with-
drawal from each substance individually [33].
Therapeutic principles
The course was primarily based on principles of motiv-
ational interviewing [29], self-control practices [34], the
relapse-prevention model [35], and methods used in
cognitive behavioural therapy that have been shown to
be effective in the cessation of tobacco [36] and cannabis
[37-39].
Although most of these principles and techniques were
applied throughout the whole duration of the course, the
emphasis on the application of each principle differed
according to the Transtheoretical Model of Behavior
Change [40]. Consequently, motivational enhancement
strategies predominated in the early sessions of the inter-
vention to address participants’ ambivalence about quit-
ting and strengthen their motivation to change. In the
following sessions, self-control practices were highlighted,
such as an analysis of one’s own smoking behaviour with
the help of the smoking diary. After the Quit Day, relapse
prevention was the focus; relapse prevention focused on
the development of personal strategies to avoid or cope
with tobacco and cannabis use triggers.
Additionally, participants were encouraged to use
medications that are typically used as first-line medica-
tions to increase long-term tobacco abstinence [36]. As
some negative outcomes have been observed in bupro-
pion studies with cannabis users [41,42], course instruc-
tors recommended varenicline and nicotine replacement
therapy. Instructors provided information about these
medications during the information evening, handed out
leaflets that participants could take home, and indicated
the corresponding information in the workbook that
every participant received at the start of the course.
The intervention sessions that followed the informa-
tion evening occurred in a group course setting. A
meaningful part of every session was the group discus-
sion. In these discussions, the participants could share
experiences and problems, and support was provided
both among the participants and from the instructors to
the participants (i.e., intra-treatment support). Confiden-
tiality was ensured, and instructors placed great value on
providing an open, non-judgemental atmosphere. Add-
itionally, the instructors promoted the formation of
small quit teams, i.e., subgroups of two or three partici-
pants who supported each other, especially between the
course sessions, such as during episodes of strong crav-
ing. Engagement in a Quit Team was optional and the
formation and organization of the Quit Teams was not
guided by the course instructors.
Acceptability study of the integrative cessation program
We investigated the acceptability of the intervention
among the participants and course instructors. Further
analyses of smoking-related outcomes and utilisation will
be conducted with the follow-up data in the near future.
Sampling and recruitment
Course participants were recruited with the above-
mentioned methods. To be included in the intervention,
participants had to use cannabis at least weekly, smoke
tobacco (in addition to any tobacco used in joints) daily,
be at least 18 years old, and be German literate. Partici-
pants were not reimbursed, but participation was free,
which may have been attractive because, in Switzerland,
tobacco cessation programmes usually require payment
from the participants themselves.
Recruitment of course instructors began within the ex-
pert team that developed the intervention. As mentioned
above, some experts also acted as course instructors.
The experts also trained co-workers from their institu-
tions to guide the courses.
Measurements and analyses
At the end of treatment, participants completed ques-
tionnaires that they received either at the end of the last
session or by mail if they missed the last session. The
questionnaire contained a set of items that measured the
participants’ opinions toward the intervention in general
and toward several components of the intervention. The
instruction for the general items began as follows: “How
would you evaluate the course regarding”. The instruc-
tion for the course component items began as follows:
“How helpful were the following components for you?”
All items were rated on a scale from 0 to 5, and higher
values indicated more positive evaluations.
The course instructors received an analogous evalu-
ation form after they had conducted the last course and
indicated to what extent the course components were
helpful to the participants.
In addition to descriptive statistics, the ratings for the
general items were compared between participants of
the first (five course sessions) and second implementa-
tion phases (six course sessions) using Mann–Whitney
U tests. This comparison was not applied to the specific
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course components because their contents did not differ
between the two phases.
Ethical approval
This intervention study was performed in compliance
with the Declaration of Helsinki and was reviewed by
the Ethics Committee of the Canton of Zurich, which
did not declare any objections (KEK-StV-Nr.23/11). Par-
ticipants signed an informed consent form prior to the
first group therapy session.
Results
Sample characteristics
Over nine months, a total of 77 co-smokers participated
in seven groups with six to 13 participants each. Of
these participants, 59 (76.6%) answered at least one item
of the course evaluation. Of these 59, 31 participated
during the first and 28 during the second implementa-
tion phase. The majority of the respondents (71.2%)
were male, their mean age was M = 34.0 (SD = 8.1) years,
and most (84.7%) were Swiss. Regarding educational at-
tainment, 33.9% had a university degree, 51.5% had com-
pleted secondary education (the majority of these
participants had finished an apprenticeship), 5.1% had
finished primary school, 3.4% had no degree, 3.4% had a
degree not listed, and 1.7% did not answer this question.
In addition to the participants, all course instructors
(N = 8, 3 females) completed the evaluation form.
Participants’ and course instructors’ evaluations of the
intervention
Overall, the course was rated positively by the participants
(M = 3.9, SD = 1.1) and course instructors (M = 4.3, SD =
0.5). Regarding its comprehensibility, participants and
course instructors evaluated the course very positively
(M= 4.5, SD = 1.0 andM = 4.3, SD = 0.7, respectively). The
ratings of the courses’ atmosphere were comparatively
high (participants: M = 4.3, SD = 1.1; course instructors:
M = 4.5, SD =0.5). Participants rated the opportunity to
openly discuss illegal issues particularly high (M = 4.6,
SD = 1.0), and the course instructors also provided high
ratings on this measure (M = 4.3, SD = 0.7). As displayed
in Table 3, compared to the ratings of the phase 1 partici-
pants, the ratings of the phase 2 participants tended to be
higher across all general items. These differences were sta-
tistically significant for the overall evaluation and the
evaluation of comprehensibility.
Table 4 summarises the participants’ and course in-
structors’ evaluations of the different course compo-
nents. Participants particularly appreciated the analysis
of the consumption diary (M = 4.1, SD = 1.1), which was
usually accompanied by an extensive group discussion
involving exchanges of experiences between the partici-
pants. With the exception of “handling of social risk
situations”, participants and course instructors provided
high ratings of all the modules that aimed at developing
concrete, personal strategies for handling problems that
can occur during smoking cessation. Course instructors
also considered the carbon monoxide measurement as
helpful for the participants. Of all the course compo-
nents, the Quit Teams which were an optional element
received the lowest ratings from both the course instruc-
tors (M = 3.3, SD = 1.0) and the 38 participants who indi-
cated that they have been a member of such a Quit
Team (M = 2.4, SD = 1.7).
Discussion
This study describes the development and content of the
first integrative group cessation program for co-smokers
of tobacco and cannabis. The program was developed
after a preliminary study revealed that both experts and
co-smokers of cigarettes and cannabis demanded com-
bined interventions to address simultaneous tobacco and
cannabis cessation. This result is consistent with previ-
ous theoretical discussions [1,26,27].
During the preliminary study, experts stressed the
multi-dimensional relationship between tobacco and
cannabis use that is particularly evident during cessation
attempts. Many consumers reported experiencing the
balancing effect mentioned by the experts (i.e., the in-
creased use of the other substance after quitting the first
substance). However, among the queried co-smokers,
there was only a modest level of readiness to quit to-
bacco and cannabis simultaneously and of readiness to
participate in an ISCP that addressed both substances at
the same time. Many co-smokers were not aware of the
relationship between tobacco and cannabis use or the
harmful physical health consequences of smoking canna-
bis. This lack of awareness might explain the modest
level of readiness to quit simultaneously. To overcome
this lack of awareness and knowledge, the interdisciplin-
ary expert team developed a participant recruitment
strategy that was an integral part of the ISCP.
The recruitment for the courses was a success because
77 participants were recruited, and seven courses were
accomplished within a relatively short time frame of nine
months. This success may be attributable to two factors.
First, course participation was free of charge because the
ISCP was still in development. In Switzerland, partici-
pants are usually required to pay for their own participa-
tion in tobacco cessation programs. Thus, participation
rates may change when the program cannot be offered
free of cost. Second, after the press release and a report
that appeared in a common free commuter newspaper
at the beginning of the first implementation phase, par-
ticipation rates for the information evening and the
course itself were especially high. Because this strategy
cannot be applied regularly, it is necessary to switch to
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appropriate alternatives in the future. In Switzerland,
these alternatives could include regular advertisements
in the two most common commuter newspapers, which
reach a large part of the population.
According to their evaluations of the course, both the
participants and the course instructors found the ISCP
highly acceptable. Because the items measuring the gen-
eral acceptance of the course were rated more positively
by the participants of the second implementation phase,
a course length of six, rather than five, sessions may be
more appropriate. The finding that participants espe-
cially appreciated the group discussions indicates that
group settings are appropriate for targeting co-smokers
of tobacco and cannabis. Furthermore, participants and
course instructors valued those course modules that
aimed at developing strategies which can be applied
when quitting tobacco and cannabis use. Additionally,
the course instructors considered the carbon monoxide
measurements to be helpful. Thus, these measurements
should remain part of the intervention when the scien-
tific evaluation is completed and biochemical validation
is not needed any longer.
The Quit Teams were the least appreciated course
element and only two thirds of the participants engaged in
a Quit Team. Possibly the participants felt no need of this
optional buddy support system because the group setting
provided sufficient social support. Thus, exclusion of the
element of Quit Teams could be considered for a future
version of the program. This conclusion is supported by
two studies which show that buddy systems provide an
additional benefit in an individual smoking cessation set-
ting [43] but not in a group setting [44].
The ISCP developed in this study combines two sub-
stances in one cessation program and connects profes-
sionals from general health provider services and
psychiatric services. Consequently, the professionals
from these services will learn and potentially benefit
from their complementary knowledge and experiences.
However, beyond this intervention, policy makers should
be sensitive to the issue of tobacco and cannabis co-use.
Furthermore, the treatment of co-use should be
implemented in the health care system and should be
covered by existing basic health insurance. The public
health approach of Screening, Brief Intervention, and
Referral to Treatment (SBIRT) could be applied to the
co-use of tobacco and cannabis. Thus, screening for to-
bacco use in primary care settings could be extended to
include screening for co-smoking. Depending on the se-
verity of co-smoking and the willingness to quit, practi-
tioners could then provide information and advice and
refer co-smokers to targeted interventions such as the
one presented here. Proactive strategies like this may be
capable of reaching a broad range of co-smokers and
prevent the intake problems that the ISCP might face
when it will be conducted without the media interest
Table 3 General course evaluations from the participants of implementation phases 1 and 2
How do you evaluate the course… Phase 1 participants Phase 2 participants Mann–Whitney-U
test(n = 31) (n = 28)
M (SD) M (SD) U p
…overall 3.6 (1.1) 4.1 (1.0) 306.0 .041
…regarding its comprehensibility 4.2 (1.2) 4.8 (0.5) 258.5 .018
…regarding the atmosphere 4.1 (1.2) 4.5 (0.9) 290.5 .100
…regarding the possibility to openly discuss illegal issues 4.4 (1.1) 4.8 (0.7) 302.5 .100
Items were answered on a scale ranging from 0 (not good at all) to 5 (very good).
Table 4 Course participants’ and course instructors’
evaluations of the course components
How helpful were the following
components for you/for the
participants?
Participants Course
instructors
(n = 56) (n = 8)
M (SD) M (SD)
Information evening 3.6 (1.5) 4.3 (1.0)
Quiz 3.3 (1.4) 4.0 (1.3)
Pro & Con 3.5 (1.4) 4.0 (0.8)
Analysis of consumption diary/group
discussion
4.1 (1.1) 4.3 (0.9)
Finding alternative rituals 3.8 (1.3) 4.4 (0.5)
Dealing with withdrawal symptoms 3.8 (1.4) 4.4 (0.5)
Goal setting 3.6 (1.4) 4.0 (0.8)
Handling of high-risk situations 3.8 (1.2) 4.3 (0.5)
Dealing with craving 3.7 (1.2) 4.6 (0.5)
Adaptation of personal strategies 3.4 (1.3) 4.0 (0.9)
Dealing with lapses 3.7 (1.3) 4.1 (0.6)
Handling of social risk situations
(Saying “No”)
3.2 (1.4) 3.6 (0.9)
Preserving achievements 3.4 (1.3) 3.6 (0.9)
Participants’workbook 3.2 (1.4) 3.6 (1.0)
Consumption diary 3.3 (1.4) 3.4 (0.9)
Carbon mononxide measurement 3.7 (1.5) 4.5 (0.8)
Quit Team1 2.4 (1.7) 3.3 (1.0)
Items were answered on a scale ranging from 0 (not helpful at all) to 5
(very helpful).
1Only the ratings of the 38 participants who were member of a Quit Team
are displayed.
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that surrounded its first implementation. Historical pre-
cedents, such as ignoring cannabis in tobacco cessation
programs and vice-versa and the use of cigarettes as re-
inforcers in psychiatry [24,25], will hopefully become is-
sues of the past.
However, the co-use of tobacco and cannabis should
not only be addressed in treatment but also in prevention.
According to the findings of our preliminary study, there
is a lack of knowledge about the relationship between to-
bacco and cannabis among co-smokers. It is likely that
smokers who only use tobacco or cannabis are not aware
of this issue, and it is possible that increased awareness
would help to prevent the initiation of the use of the sec-
ond substance among these smokers. Thus, information
about the problems associated with co-smoking should be
spread, especially among adolescents and young adults.
One limitation of this study is that the online survey
of former and active co-smokers was conducted using a
convenience sample with a wide age range, those data
are based on self-reports and retrospective cessation at-
tempt reports. Furthermore, it is difficult to disentangle
the reasons for the differences in the general evaluations
of the course between the first and the second imple-
mentation phases. Course length may be one reason, but
other factors, such as the number of participants in the
courses and the identities of the course instructors, also
varied between implementation phases.
Currently, we are conducting a thorough feasibility
study on the ISCP and expect to have the results of the
follow-up data in the autumn of 2013. More details on
this feasibility study are provided in the study’s entry at
Current Controlled Trials (ISRCTN15248397).
Conclusions
The proposed intervention for co-smokers of tobacco and
cannabis is important because it is the first group cessa-
tion program targeting these two interrelated substances
simultaneously. The developed ISCP integrates the opin-
ions of both users and experts, established therapeutic
principles, and the strategies of former tobacco and can-
nabis cessation programs. This intervention also takes into
account reasonable concepts and ideas that have emerged
from on-going discussions about the underlying mecha-
nisms and relationships between cannabis and tobacco
use, such as the common route of administration [1]. To
prevent one substance from acting as a behavioural cue
for the other [32], participants are expected to quit both
substances simultaneously. Preliminary results show that
the developed ISCP was well accepted among the partici-
pants and the course instructors. The group discussions
and the development of personal strategies for the dual
cessation of tobacco and cannabis use were particularly
appreciated. These promising results also underline the
high acceptance of the ISCP among the co-smokers, who,
for the first time, had access to a group intervention espe-
cially targeted to them.
In the near future, the presented ISCP will be evalu-
ated for feasibility and initial efficacy.
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